申请人:Nirsum Laboratories, Inc.
公开号:US20190307743A1
公开(公告)日:2019-10-10
Provided herein are prodrugs of opioid receptor antagonists such as nalmefene and naltrexone, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of behavioral disorders.